Ghent University Academic Bibliography

Your filters: cql: author="Murgaski, Aleksandar" or (type any "bookEditor issueEditor" and editor="Murgaski, Aleksan...

Add to list
- Journal Article
- A1
- open access
Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

Aleksandar Murgaski, Mate Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E. I. Hamouda, et al.

(2022) CANCER RESEARCH. 82(20). p.3785-3801
Add to list
- Journal Article
- A1
- open access
Macrophages are metabolically heterogeneous within the tumor microenvironment

Xenia Geeraerts, Juan Fernandez-Garcia, Felix J. Hartmann, Kyra E. de Goede, Liesbet Martens (UGent) , Yvon Elkrim, Ayla Debraekeleer, Benoit Stijlemans, Anke Vandekeere, Gianmarco Rinaldi, et al.

(2021) CELL REPORTS. 37(13).
Add to list
IL1 beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D

Mate Kiss, Lieselotte Vande Walle (UGent) , Pedro Henrique Viana Saavedra (UGent) , Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, et al.

(2021) CANCER IMMUNOLOGY RESEARCH. 9(3). p.309-323
Add to list
- Journal Article
- A1
- open access
Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

Helena Van Damme, Bruno Dombrecht, Mate Kiss, Heleen Roose, Elizabeth Allen, Eva Van Overmeire, Daliya Kancheva, Liesbet Martens (UGent) , Aleksandar Murgaski, Pauline Madeleine Rachel Bardet, et al.

(2021) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 9(2).
Add to list
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

Evangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, Danielle Berus, Geert Stange, Emile J Clappaert, Sana Arnouk, Ana Rita Pombo Antunes, Ahmet Krasniqi, Tony Lahoutte, et al.

(2019) JOURNAL OF CONTROLLED RELEASE. 314. p.1-11

Academic Bibliography

Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

Macrophages are metabolically heterogeneous within the tumor microenvironment

IL1 beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D

Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

Contents

Support

Contact